Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant
Authors:
- 22 December 2003
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 33 (4) , 419-423
Abstract
We assessed the prognostic importance of the platelet count 100 days post transplant of 107 consecutive patients receiving ablative allogeneic bone marrow transplant (BMT) between 7/96 and 12/00 who survived at least 100 days. Diagnoses included AML (n=36), chronic myelogenous leukemia (n=27), NHL (n=14), ALL (n=16), MDS (n=9), aplastic anemia (n=3), and one Hodgkin's disease and myelofibrosis each. In total, 64% were in remission or in chronic phase or had aplastic anemia (good risk), and 36% had active disease at the time of transplant (bad risk). In all, 70% were matched sibling transplants and 30% were matched unrelated donor transplants. The mean follow-up for the patients remaining alive is 48 months. Survival was powerfully influenced by the 100-day platelet count: 4-year survival was 19% for patients with a platelet count 9/l; 41% for patients with a platelet count of 30–50; and 72% for those with a platelet count >50 (PPP=0.009). We conclude that the platelet count 100 days post transplant is a powerful predictor of overall survival.Keywords
This publication has 23 references indexed in Scilit:
- Recursive Partitioning in the Health Sciences1999
- Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysisBone Marrow Transplantation, 1998
- The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantationBone Marrow Transplantation, 1998
- Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 yearsLeukemia, 1997
- Outcome After Allogeneic Bone Marrow Transplant for Leukemia in Older AdultsJAMA, 1993
- Pretransplant Pulmonary Function Predicts Cytomegalovirus-Associated Interstitial Pneumonia following Bone Marrow TransplantationChest, 1992
- Predictive Value of Pulmonary Function Tests before Marrow TransplantationChest, 1992
- RISK FACTORS FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN HISTOCOMPATIBLE DONOR BONE MARROW TRANSPLANTATIONTransplantation, 1991
- Risk factors for acute graft‐versus‐host diseaseBritish Journal of Haematology, 1987
- Bone Marrow Transplantation for Acute Myelogenous LeukemiaJAMA, 1983